Texas Biotech to launch Argatroban

TXB and marketing partner SmithKline Beecham (SBH; LSE:SB) expect to launch in October TXB's Argatroban synthetic thrombin inhibitor to prevent or treat thrombosis associated with heparin-induced thro...